Sunday, January 31, 2021 1:33:44 AM
So from tomorrow and the next few weeks there will definitely be time to add up and the exchanges and the market are always trading the future and RVVTF (RVV) is just beginning and has a great future ahead of it, so now would be the time
Thank you for sharing your thoughts and I think it's good that we should definitely get phase 3 approval by May or maybe April, a period that all shareholders can still wait.
.
Thank you for sharing your thoughts and I think it's good that we should definitely get phase 3 approval by May or maybe April, a period that all shareholders can still wait.
.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
